Hunter Associates Investment Management’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Hunter Associates Investment Management’s Portfolio LFSC Stock Details LFSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.61M	Buy	57,742 +8,003	+16%	+$310K	0.3%	74
2026 Q1	$1.74M	Buy	49,739 +3,831	+8%	+$136K	0.23%	99
2025 Q4	$1.68M	Buy	45,908 +5,312	+13%	+$182K	0.23%	102
2025 Q3	$1.21M	Sell	40,596 -144	-0.4%	-$3.85K	0.17%	114
2025 Q2	$1M	Buy	40,740 +4,101	+11%	+$93.9K	0.15%	123
2025 Q1	$820K	Buy	36,639 +11,329	+45%	+$276K	0.13%	143
2024 Q4	$590K	Buy	+25,310	New	+$641K	0.09%	161

Other funds holding LFSC

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

CCWP

Cedar Cove Wealth Partners Bloomington, Minnesota $213M AUM

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

OPA

Old Port Advisors Portland, Maine $508M AUM 50.99% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hunter Associates Investment Management's LFSC Position: Q2 2026 in Review

Hunter Associates Investment Management increased its F/m Emerald Life Sciences Innovation ETF (LFSC) stake by 16% in Q2 2026, buying an estimated $310K and bringing the position to 57,742 shares worth $2.61M. The position accounts for 0.3% of the portfolio, ranked #74.

Hunter Associates Investment Management first reported a position in LFSC in Q4 2024 and has held it in 7 quarters since. 8 funds tracked by Wall St. Rank hold LFSC as of Q2 2026.

Hunter Associates Investment Management held 57,742 shares of F/m Emerald Life Sciences Innovation ETF worth $2.61M as of Q2 2026.
Hunter Associates Investment Management bought 8,003 F/m Emerald Life Sciences Innovation ETF shares in Q2 2026, an estimated $310K.
F/m Emerald Life Sciences Innovation ETF made up 0.3% of Hunter Associates Investment Management's portfolio in Q2 2026, its #74 holding.
Hunter Associates Investment Management first reported a position in F/m Emerald Life Sciences Innovation ETF in Q4 2024 and has held it in 7 quarters since.
8 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.